United Health Settlement Ends 13-Year Provigil Saga (Corrected)

The long-running antitrust saga involving alleged efforts to block generic competition for the wakefulness drug Provigil appears to have reached its conclusion.

Insurance giant United Healthcare Services Inc.'s lawsuit against six drug companies was dismissed July 26 by Judge Mitchell S. Goldberg of the U.S. District Court for the Eastern District of Pennsylvania, who oversaw the multidistrict litigation.

United settled on undisclosed terms with the remaining defendants, Mylan Laboratories Inc. and Sun Pharmaceutical Industries Ltd., according to Goldberg’s order.

United appears to have been the last plaintiff out of hundreds that accused Cephalon Inc. of resolving its patent infringement ...